Navigation Links
BioInformatics LLC [Webcast] – RateMyProduct™: Find Out Why Life Science Suppliers Are Using It, August 14, 2013
Date:8/13/2013

Arlington, VA (PRWEB) August 13, 2013

BioInformatics LLC, life science industry market research experts, will be holding a webcast to discuss RateMyProduct™. RateMyProduct is BioInformatics LLC’s proprietary lab product assessment tool that provides life science suppliers with customer feedback about suppliers’ instruments, consumables and services.

This free 30 minute webcast will take place on August 14, 2013 at 1PM EDT.

Register here.

RateMyProduct enables life science marketing and product managers to have products reviewed by selected target markets and get an online report within 5 business days. The automatically generated online report provides feedback from prospective customers on the following predictors of market success:

  • Market Receptivity
  • Innovation
  • Product Utility
  • Purchase Criteria
  • Pricing Appropriateness
  • Message Effectiveness
  • Differentiation
  • Overall RMP Score

Prospective customers who evaluate the products are drawn from The Science Advisory Board – an expert network of more than 73,000 scientists engaged in biological research, drug discovery and biopharmaceutical production.

“In our two decades of conducting market research on scientific markets, we have become adept at recognizing common pain points among product managers who are charged with bringing blockbuster products to market on a limited budget,” says Bill Kelly, president of BioInformatics LLC. “With RateMyProduct, we have created an automated tool to quickly and easily capture product performance data—all for a fraction of the cost of traditional market research.”

RateMyProduct is being introduced at a price of $1,500 for a summary report that contains value scores on a single product or service. RateMyProduct is available for fielding in two geographic regions—Europe and the United States.

Click here to register for the webcast.

About BioInformatics LLC

BioInformatics LLC is the premier research and advisory firm serving the life science industry. By leveraging our expert network of more than 71,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:

Mary Follin
Manager, Marketing/Sales
BioInformatics LLC

2111 Wilson Blvd., Suite 250
Arlington, VA 22201

703.778.3080 x13 (phone)

m.follin(at)gene2drug(dot)com

http://www.gene2drug.com/

Read the full story at http://www.prweb.com/releases/2013/8/prweb11022708.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioInformatics, LLC Deploys RateMyProduct™ to Rate Benchtop Real-time PCR Machines
2. BioInformatics LLC—New Report Finds High Degree of Satisfaction With Instrumentation Performance Among Researchers
3. BioInformatics, LLC New Market Research Report – Life Science Instruments: Brand Performance
4. Bioinformatics Market Worth $7.5 Billion by 2017
5. BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004)
6. Bioinformatics: Technologies and Global Markets
7. Japan Bioinformatics Announces Release of a Case Study on Detecting SNPs and Short INDELs
8. Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
9. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
10. Scientists Warn of Long Term Consequences of Budget Sequestration: BioInformatics LLC Report
11. BioInformatics LLC Multi-Sponsor Market Report – In-depth Exploration of the U.S. Market for Biosimilar Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... Parallel6™ ... clinical trials worldwide, announced today that they were named one of the 2017 ... covers the latest developments in the pharmaceutical industry. , “We take pride in honoring ...
(Date:4/20/2017)... Israel , April 20, 2017  BrainStorm ... stem cell technologies for neurodegenerative diseases, announced today that ... Alliance for Regenerative Medicine,s (ARM) 5 th Annual Cell ... at 09:40 EDT in Boston . ... Chief Medical Officer & Chief Operating Officer, will participate in ...
(Date:4/19/2017)... ... , ... A number of new instruments have recently emerged to accommodate different ... Protein and Cell Analysis Education Webinar Series , will focus on advances in the ... future applications. , Many flow cytometers have unique capabilities and the Attune NxT ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion of Landmark ... Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, ... trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of Panic ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):